直接作用的抗病毒药物和针对肠道病毒B感染的宿主向方法:最近的进展
Chiara Tammaro1, Michela Guida1, Federico Appetecchia1
1Department of Chemistry and Technologies of Drug, Sapienza University of Rome, Piazzale A. Moro, 5, 00185 Rome, Italy.
Pharmaceuticals (Basel, Switzerland)
|June 1, 2023
概括
由于目前的治疗方法有限,迫切需要针对肠道病毒B (EV-B) 感染的新型抗病毒药物. 本综述强调了最近在抗病毒化合物和对EV-B的药物重新定位方面的发现.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 肠道病毒B (EV-B) 感染对健康构成重大风险,特别是在脆弱人群中.
- 目前对EV-B疾病的临床治疗严重依赖于支持性护理,缺乏向的抗病毒疗法.
- 越来越多的EV-B的临床影响需要开发有效的抗病毒干预措施.
研究的目的:
- 审查最近在识别新型抗病毒化合物对抗肠道病毒B的进展.
- 探索用于治疗EV-B感染的现有药物的再利用所取得的进展.
- 讨论EV-B药物发现的当前趋势和未来方向,确定研究缺口.
主要方法:
- 对抗EV-B抑制剂的研究进行全面的文献搜索.
- 对新型抗病毒化合物开发的最新发现进行分析.
- 对用于EV-B感染的药物重新定位策略的审查.
主要成果:
- 已经确定了许多具有高选择性和有前途的体外活性针对EV-B的潜在抗病毒化合物.
- 在药物的重新用途方面取得了进展,提供了替代治疗途径.
- 该审查整合了目前的调查结果,并突出了需要进一步调查的领域.
结论:
- 在发现新型抗EV-B剂方面取得了重大进展.
- 药物重定向是一种可行的策略,可以加速EV-B的治疗开发.
- 进一步的研究至关重要,以解决现有的差距,并开发有效的治疗方法来对抗EV-B疾病.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


